
Recovery and Quality of Life
Impulsivity and Recovery Outcomes
The phenotype of recovery II: The association between delay discounting, self-reported quality of life, and remission status among individuals in recovery from substance use disorders
Liqa N. Athamneh; Roberta Freitas Lemos; Julia C. Basso; Devin C. Tomlinson; William H. Craft; Madison D. Stein; Warren K. Bickel
Experimental and Clinical Psychopharmacology
2022 February
Summary
This article investigates how delay discounting relates to quality of life and remission status among individuals in recovery from substance use disorders. The study frames delay discounting as a behavioral marker of impulsive decision-making and examines whether it is connected to meaningful recovery outcomes beyond substance use alone. Findings suggest that lower delay discounting is associated with better remission-related outcomes and higher self-reported quality of life. The article supports the idea that recovery should be understood as multidimensional, including both abstinence or remission status and broader well-being.
Key Findings:
Lower impulsivity is associated with better recovery outcomes and higher quality of life.
Implications:
Targeting impulsivity may improve long-term recovery outcomes and quality of life.

